Dear Members, We all know the World Health Organization has declared the H1N1 virus outbreak to be a pandemic. Here it is the last week of July, and flu season will be here a lot sooner than many of us have expected. If you are like me you are not wanting to just sit back and do nothing. You want to be proactive with your family and find a way to prevent the virus from affecting your family. We all remember the hype in the media from April and May. Most of the news coverage has let up in the United States for the Summer. We all know how things work. As soon as it gets serious here in the US, the media will pick up on the story again and make it the top item again. Is there anything we can do to protect our families and ourselves? Is there a company with an innovative product that is capable of helping in this effort? One product cannot do everthing, but there is a product that can help. It is from a well established fully reporting company that you can buy shares in. I want to introduce a company I had the honor to go out and visit last week at their headquarters in Las Vegas, Nevada. The company is Skinvisible (OTCBB: SKVI). Before I introduce to you the product we are speaking of, realize this company is not a one product start-up. The company has been around for years and has many successful products that are marketed around the world. This company is strong even if they did not have what appears to be one of the best products for stopping and killing the H1N1 Virus. DermSafe is the product. Let me tell you about DermSafe. This product is much like the hand sanitizers that you are used to. Just like with hand sanitizers, one application and you feel you kill virtually all of the H1N1 virus. What makes this product more important is that the killing continues and continues. Up to four hours after the application your hands are still killing the virus as you touch other surfaces and shake hands. Even if you wash your hands, the patented polymer keeps the power of DermSafe working. Skinvisible has developed an innovative polymer delivery vehicles and related compositions that hold active ingredients on the skin for extended periods of time when applied topically. The polymer delivery vehicles allow for normal skin respiration and perspiration. The polymer compositions wear off as part of the natural exfoliation process of the skin’s outer layer cells. Skinvisible’s process is formulated without the use of alcohol, silicones, waxes, or other organic solvents. Skinvisible has two U.S. Patents and has been granted patents in India, Australia, Japan and China.

Dear Members,

THE WORLD HEALTH ORGANIZATION DECLARES H1N1 A PHASE 6 PANDEMIC

We all know the World Health Organization has declared the H1N1 virus outbreak to be a Phase 6 Pandemic. Here it is the last week of July, and flu season will be here a lot sooner than many of us have expected. If you are like me you are not wanting to just sit back and do nothing. You want to be proactive with your family and find a way to prevent the virus from affecting your family. We all remember the hype in the media from April and May. Most of the news coverage has let up in the United States for the Summer. We all know how things work. As soon as it gets serious here in the US, the media will pick up on the story again and make it the top item again.

Is there anything we can do to protect our families and ourselves? Is there a company with an innovative product that is capable of helping in this effort?

.

A COMPANY YOU CAN INVEST IN WITH A PRODUCT THAT CAN HELP FIGHT H1N1

The company is Skinvisible (OTCBB: SKVI)

.

One product cannot do everthing, but there is a product that can help. It is from a well established fully reporting company that you can buy shares in. I want to introduce a company I had the honor to go out and visit last week at their headquarters in Las Vegas, Nevada. The company is Skinvisible (OTCBB: SKVI).

Before I introduce to you the product we are speaking of, realize this company is not a one product start-up. The company has been around for years and has many successful products that are marketed around the world. This company is strong even if they did not have what appears to be one of the best products for stopping and killing the H1N1 Virus.

DermSafe is the product.

Let me tell you about DermSafe. This product is much like the hand sanitizers that you are used to. Just like with hand sanitizers, one application and you feel you kill virtually all of the H1N1 virus. What makes this product more important is that the killing continues and continues. Up to four hours after the application your hands are still killing the virus as you touch other surfaces and shake hands. Even if you wash your hands, the patented polymer keeps the power of DermSafe working.

Skinvisible has developed an innovative polymer delivery vehicles and related compositions that hold active ingredients on the skin for extended periods of time when applied topically. The polymer delivery vehicles allow for normal skin respiration and perspiration. The polymer compositions wear off as part of the natural exfoliation process of the skin’s outer layer cells. Skinvisible’s process is formulated without the use of alcohol, silicones, waxes, or other organic solvents. Skinvisible has two U.S. Patents and has been granted patents in India, Australia, Japan and China.

When can you buy the product? The product is approved in Canada, and should soon be approved in the UK and Europe if the process goes as expected. China is also a market that is likely to be approved soon. The process there is underway as well. There have been some efforts to get it on a fast track approval for FDA approval. So far the FDA is not willing to let that happen. The company will certainly pursue normal channels for making the product available in the US. Skinvisible has much experience with this, so I think they will have eventual success. The opportunity here and now is all of the rest of the world. Should the FDA approval come at some point, it will be a bonus on top of the rest of the world. Do not look for that this year. For good reason the FDA is careful. The active ingredient in this product is well known and has been used in hospitals for years.

.

THE CAPITAL STRUCTURE:

COMMON STOCK ONLY – NO PREFERRED ISSUES

.

As your do your research and due diligence, I personally think you will see the opportunity here. Take note of the capital structure here. There are NO PREFERRED issues. The common shares the insiders have are the same shares you will buy. This is a very clean deal that has a great product.

I see the stock as serious undervalued based on everything else the company has to offer. When you factor in DermSafe, you can really see there is a lot of potential here.

.

MY ESTIMATE

I am not going to give you a target price, but I will tell you this is very undervalued. Once DermSafe is on product shelves, we should see the stock do great revenue and as a result do multiples in pricing. That will happen this Fall, so get ready.

FYI, once a link is live that allows you to buy from a reputable Canadian Pharmacy web site, I will share that with you. I know many of us would love to not only have some shares but the product as well! I will keep you informed.

I would love to hear your comments.

John Pentony
Publisher, StockGuru

.

StockGuru Profile for Skinvisible, Inc.

.

Any discussion of Skinvisible needs to start with a discussion the H1N1 virus and Skinvisible’s product Derm Safe. Our profile has information on the entire company as you will find below. Note that this company can stand alone without DermSafe – and has for years. First the H1N1 problem:

.

.

How Big is the H1N1 Problem?

.

.

As of July 24, 2009 as we initiallypublish this profile, the World Health Organization ("WHO" estimates that as amny as TWO BILLION PEOPLE could become infected with H1N1 over the next two years. That is nearly ONE-THIRD of the world’s population.

Authorities in Britain say there were over 100,000 infections in England alone last week, while U.S. health officials estimate the United States has passed the 1 million case mark. Those figures dwarf WHO’s tally of 130,000 confirmed cases worldwide since the start of the outbreak last Spring.

The search for an effective inoculation has taken on a new urgency as WHO announced that almost 800 people have died from the disease in the past four months. This is more than the H5N1 bird flu strain has killed in six years.

What are the projected estimates for infection in the United States? This from the Center for Disease Control (“CDC”):

The CDC said Friday that – based on the experience of the 1957 flu pandemic – the number of Americans dying from swine flu over the next two years could range from 90,000 to several hundred thousand. That projection would drop if the vaccine campaign and other measures are successful, U.S. health officials said.

On Friday, July 24, the Associated Press released an interview with Keiji Fukuda, WHO’s Assistant Director-General for Health Security and Environment. Here are some of his comments:

“We haven’t seen widespread emergence of resistance to the drug right now,”; Fukuda said, but added “this is something we’re watching very carefully.”

It is inevitable that over a long enough period of time the swine flu virus will mutate, he said. “Unfortunately we can’t predict in what direction,” he said.

More of that interview can be found here:

http://news.aol.com/article/who-flu-chief-no-compromise-on-vaccine/586847?cid=14

Is DermSafe Effective in Killing H1N1 Virus?

In a word, YES. The killing action last for up to four hours.

A research and development company of patented skincare and medical dermatology products, previously announced that DermSafe, the Company’s hand sanitizing lotion, was proven effective in killing the H1N1 virus. The studies were conducted by Retroscreen Virology of London, England, U.K. demonstrating a greater than 99.99% inactivation/kill on the H1N1 influenza A virus. Most importantly, the killing action last up to four hours.

.

.

.

A Comprehensive Look at Skinvisible:

.

Like I said, this company can stand alone without DermSafe. The good news is that is not a reality. They do have this product. When you look at Skinvisible, you are look at a company that has been around since 1999. I personally visited their Las Vegas headquarters less than two weeks ago. They have been in the same offices for the past decade. I met their researchers and everyone responsible for the great success they have already generated.

Company Highlights:

• Skinvisible has 6 patents approved including the US, India, Australia, China and Japan, 9 U.S. patents pending in addition to 34 PCTs internationally, with many more to be filed. Some of these PCT patents cover up to five products.
• DermSafe, the Company’s hand sanitizing lotion, was proven effective with a greater than 99.99% inactivation/kill on the H1N1 influenza A virus
• Skinvisible has licensed three of its prescription acne formulations
• Skinvisible has licensed three over-the-counter products; two for $1 million each

Skinvisible has 25 different product formulation made with their patented technology targeting nine different indications

Revenue Source

Skinvisible has four sources of revenue:

1. Licensing Fees
2. Research and Development Fees
3. Sales of Polymers
4. Royalties from Licensed Polymers

Skinvisible’s Core Strengths

1. Patents: Intellectual property Invisicare is protected internationally and new patents in progress
2. Pipeline: Products available in ten key categories, with more than 25 formulations many with international patents pending; a cost-effective solution for companies seeking products to license
3. The People: Specialized scientists, experienced Board of Directors, expert pharmaceutical & medical consultants, all focused on the Company’s success

Business Licensing Model

Skinvisible does not manufacture or sell products itself, instead the Company licenses out all of its product formulations made with Invisicare to pharmaceutical, medical and consumer goods companies. There is an upfront license fee for exclusive distribution for a specific territory (or worldwide), royalties and development fees if required. They supply the licensee with the formula and manufacturing instructions. They also work with companies with their own IP, products coming off patent, or looking for life cycle management for current products through new IP, line extensions or product enhancements.

Process for Combining Water Soluble and Insoluble Polymers

The patented Invisicare technology is used to produce a variety of prescription dermatology and over-the-counter skincare products along with hospital-related and consumer goods products that address a variety of medical conditions. Products in the pipeline are considered to be those which have been developed by Skinvisible in response to a variety of topical skin applications and product development opportunities identified both independently and in collaboration with established manufacturers and marketers.

Invisicare® Benefits

• Displays superior skin adherence for extended time periods
• Non-occlusive yet resists water wash-off, respiration and perspiration
• Increased efficacy of active ingredients
• Allows for lower use levels of actives with increased persistence of effect
• Offers advantage of controlled and/or sustained time-release
• Highly compatible with a variety of actives and bases
• Easy to emulsify
• Formulates well at a cream, lotion, or spray viscosity
• Non-irritating emulsion dries quickly with no greasy after-feel
• Non-occlusive film forms protective barrier against environmental irritants
• Broad polymer selection to meet application requirements
• Offers “Life Cycle” management to core products with potential for new patent
• Simplified manufacturing process

Products Using Invisicare®

Products that successfully incorporate Invisicare® to date include antimicrobial hand sanitizer lotions, suncare products, skincare moisturizers, sunless tanning products as well as various dermatology products for various skin disorders. On an ongoing basis the Company is seeking to develop polymer formulations that can successfully be incorporated into other products.

Licensing of Invisicare

SKVI’s primary objective is to license Invisicare® to established brand manufacturers and marketers of prescription and over-the-counter products in the dermatological, medical, cosmetic, and skincare markets. With the exception of sales to one vendor, the Company’s policy is to only sell Invisicare to vendors that have executed a license agreement. Research and development is conducted in-house.

OVER-THE-COUNTER PRODUCTS LICENSED TO:

The company has signed an agreement with Panalab Internacional S.A. for their anti-acne product formulated with Adapalene (licensed territories – Argentina, Brazil and Chile).

The company signed an agreement with Embil Pharmaceutical Co. Ltd. for products formulated with the active ingredients Clindamycine HCL and Retinoic Acid (licensed territories countries in Eastern Europe and three in South East Asia.

SKINVISIBLE’S BLOCKBUSTER PRODUCT – DERMSAFE®

DermSafe Hand Sanitizer Lotion

Skinvisible’s DermSafe® is an antimicrobial hand sanitizer that has the unique ability to kill bacteria and kill/inactivate viruses on the hands for four hours or longer. DermSafe stays bound to the hands, even after frequent washings. This is considered to be a real plus for doctors and nurses as they move from patient to patient.

The Company intends to begin marketing Chlorhexidine Hand Sanitizer Lotion “DermSafe” in Canada in the third quarter of 2009. The Company expects to file for US FDA approval with a marketing partner in 2009 for this unique product that is needed immediately by the general public,

DermSafe is alcohol-free, and consequently eliminates fire, safety and skin drying issues associated with alcohol-based products. DermSafe also contains the patented technology Invisicare which allows the product to stay bound to the skin. The active ingredient, 4% chlorhexidine gluconate, has been safely used in pre-surgical scrubs worldwide for over 50 years.

Recent Developments

Effective in Killing H1N1 Virus:

The Company previously announced that DermSafe, their proprietary hand sanitizing lotion, was proven effective in killing the H1N1 virus. The studies were conducted by Retroscreen Virology of London, England demonstrating a greater than 99.99% inactivation/kill on the H1N1 influenza A virus.

The spread of this virus and the declaration of a pandemic by the World Health Organization (WHO) has increased Skinvisible’s efforts in the global licensing of DermSafe. On June 11, 2009, WHO raised their pandemic threat to a Phase 6 – “the virus is contagious, spreading easily from one person to another and from one country to another.” On the same date over 30,000 cases were confirmed in 74 countries. Less than one month later, the confirmed cases tripled in number to over 94,000, and the number continues to grow.

In the United States, the CDC estimates that over one million Americans currently have the flu virus, while Canadian health officials estimated that over 30% of Canadians or 10 million people will come down with this virus in the coming flu season. The British health minister stated that by the end of August, Britain could experience 100,000 new cases each day. In the southern hemisphere, where it is now winter, Argentina’s health minister reports that the number of deaths due to the H1N1 influenza A virus had reached 137, with a total of 3,056 officially confirmed cases. Many believe the actual toll to be much higher.

Markets for DermSafe:

In Canada DermSafe has received approval allowing the sale of DermSafe for personal use.

In the United States DermSafe requires approval by the Federal Drug Administration (FDA The FDA has opened a Pre-Investigational New Drug (Pre-IND) file for DermSafe. Globally: Skinvisible and select consultants are working with the appropriate governmental regulatory bodies to obtain marketing approvals and to acquire licensees. DermSafe is available for licensing both commercially in healthcare and food services as well as for personal use (retail) worldwide.

Skinvisible is working with potential licensees for DermSafe in the United States, Canada, China, Hong Kong, Singapore and other parts of Southeast Asia, Japan, the United Kingdom, Europe, Australia, Africa and Mexico.

In some countries the product requires little or no regulatory approval.

Products in the Pipeline

Products in the pipeline are considered to be those which have been developed by Skinvisible in response to a variety of topical skin applications and product development opportunities identified both independently and in collaboration with established manufacturers and marketers.

These products have been successfully tested in-house to determine “proof of concept” stability, proven active agent activity and sustained release) and are currently ready to be licensed to established pharmaceutical, OTC, cosmetic or skincare manufacturers for commercialization. Regulatory approvals may be required for some products.

Skinvisible’s Invisicare pipeline includes topical products for the following condition or use:

• Acne
• Topical Analgesics and First Aid
• Anti-Aging
• Anti-Fungal
• Anti-Inflammatory
• Antimicrobial Hand Sanitizing Lotions
• Dermatitis/Moisturizers
• Skin Cancer
• UVA /UVB Sunscreens
• Warts
• Other: Scar Treatment/Long-Lasting Fragrances/ Wound Care/ Pre-Surgical Treatments/ Preventative Treatments

UVA/UVB Sunscreen

A key addition to the product portfolio in 2008 was a UVA/UVB sunscreen with Parsol 1789. Parsol 1789 is the most used UVA filter in sunscreens in the US and the only ingredient approved by the US FDA that is not proprietary. The Company’s studies indicate a minimum of eight hour photostability compared to the industry average of two hours. In addition, most sunscreens, even those that indicate they are water resistant, do not remain on the skin after swimming.

With Invisicare technology, sunscreens remain on the skin for 8 to 12 hours and resist wash-off and rub-off.

..

Licensed Technology Invisicare® Polymer Delivery Vehicles

Skinvisible licenses its patented Invisicare formulations to established developers and manufacturers of dermatology, cosmetic, skincare, medical, consumer goods and surgical products, both in over-the-counter and prescription formats.

Invisicare Patents

Currently there are six patents approved including the US, Australia, India and this year Japan, nine U.S. patents pending. There are 34 patent application filed pursuant to international patent application with more to be filed. Some international patent applications reference up to five products.

• New patents on dermatology and medical products will be generated on an ongoing basis
• Every product formulated is protected by one or more patents.
• Patent approvals are sought initially in the U.S. and subsequently internationally for all products developed.

Patent Protection

Pharmaceutical companies are pursuing new or improved revenue streams along with protecting their own intellectual properties. Invisicare allows companies to sell a patent-protected product that has been revitalized with new benefits, giving them a new story to help combat generic competitors. A prescription dermatology product can generate $100 plus million per year. Some can produce even $200 plus million – and that is why the Company believes the investment into a license with an Invisicare formulation is a very viable option for these companies. Worldwide patent protection submission for products formulated with Invisicare is ongoing.

Status of Research and Development for New Applications

The Company believes that the enhancement and extension of existing products and the development of new product categories have contributed significantly to our growth to date and are necessary for continued growth.

Management evaluates new ideas and seeks to develop new products and improvements to existing products to satisfy industry requirements and changing consumer preferences. The identification of trends in consumer preferences are used to generate new product ideas. Specific to the objective of generating new products, research and development toward developing additional applications with Invisicare continues. Various developmental stages are active for the following potential applications using Invisicare.

CORPORATE HIGHLIGHTS:

Management & Board of Directors

Terry Howlett President & Chief Executive
Officer Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.

James A. Roszell Ph.D, Chemist
Dr. James Roszell is a doctoral chemist with over 35 years’ experience in product formulation, experimental design, analysis, and method validation. Since joining Skinvisible in 1998, he has been responsible for research and development of the Company’s patented technology, related polymer delivery vehicles, product formulations and compositions. Dr. Roszell is a joint contributor to Skinvisible’s Patent Number 6.756.059 and responsible for its four pending patents. Prior to joining Skinvisible, he worked as chemist for Supertech Products, Inc. in Florida where his responsibilities included ensuring compliance with OSHA, EPA\ and other standards and regulations, maintenance of quality control, research and development for new products. Dr. Roszell’s background includes work in chemical, pharmaceutical, environmental and clinical laboratory arenas. His invaluable chemical and scientific expertise are key factors in Skinvisible’s innovative technological achievements.

Doreen McMorran Vice President, Business
Development Ms. McMorran brings to the Company almost 20 years of experience in the medical and pharmaceutical industry, specifically in the areas of strategic planning, sales and marketing. She has spent the last six years selling to international dermatology and skincare focused companies like Procter and Gamble, Johnson & Johnson, Stiefel, Galderma, Novartis and Graceway, to name a few. Ms. McMorran, who holds a Bachelor of Commerce (Honours) degree, spent six years in the pharmaceutical industry with Astra Pharma. Additionally she has held senior management level positions with a number of healthcare companies, focusing on business development, sales, marketing and operations.

Board of Directors:

Brian Piwek Independent Director
Mr. Piwek’s experience and expertise is in the international retail industry. He was president of Overwaitea Foods supermarket from 1991 until 1997. In 1997 Brian accepted the position as Co-CEO with A&P Canada (The Great Atlantic & Pacific Tea Company Inc.) and in 2000 was appointed Chairman, President and CEO of A&P Canada. In late 2002 he moved to the U.S. as President and Chief Executive Officer of A&P US (New York Stock Exchange symbol "GAP") where he began the turnaround of North America’s oldest retail food chain. Brian retired from A&P in July 2005. Brian has been recognized for his achievements throughout his career including "President of the Year" by the Jim Pattison Group for the outstanding financial performance of Overwaitea in 1993. Brian is an MBA graduate and has served on many voluntary boards.

Greg McCartney
Independent Director Mr. McCartney is past President and Chief Executive Officer of Genesis Bioventures a company he founded in 1997. He was previously owner and director of a private consulting firm specializing in financing and venture capital. Mr. McCartney has over 20 years of business experience working with both private and public companies in various manufacturing and technology-based industries.

About Invisicare: Invisicare is Skinvisible’s patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. It is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time resisting both wash off and perspiration. Invisicare can control the release of actives, reduce irritation and can eliminate some costly manufacturing processes. It is non-occlusive and allows for normal skin respiration while protecting against environmental irritants. www.invisicare.com

About Skinvisible Pharmaceuticals, Inc.: Skinvisible Pharmaceuticals is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in enhancing their existing skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare patent. Skinvisible’s value also lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare. www.skinvisible.com

Forward Looking Statements: This profile contains ‘forward looking’ statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending March 30, 2009).

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC will be compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending January 30, 2010. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Medizone International, Inc. (OTCBB: MZEI) is a research and development company engaged in developing its AsepticSure^TM technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. Following the current laboratory trials, hospital mockup and hospital beta testing will begin. Initial sales are targeted to commence in the 4th quarter of this year.

Profile Facts:

The Silent Epidemic

The chart you see above represents the Nosocomial infections outside intensive care units for U.S. hospitals in 2002.

As the notes that came from the source for this chart point out, Nosocomial infections are a huge problem in hospitals today. Although this data is from 2002, the situation has progressively become more serious. Here are the notes that accompanied the chart:

“From the total number of surgical site infections (SSI) obtained from the National Hospital Discharge Dataset and the National Nosocomial Infections Surveillance (NNIS) system, we subtracted the number of SSI among newborns and adults and children in intensive care units. The remaining SSI were among adults and children outside of intensive care units. From hospital-wide surveillance in NNIS, we had the distribution of infectons by major site and calculated the corresponding number of infections for pneumonias (PNEU), urinary tract infections (UTI), bloodstream infections (BSI), and other sites.”

The Impact of Nosocomial Infections in The United States

In 2002, there were approximately 1.7 million total infections. Of these:

• 33,269 occurred among newborns in high-risk nurseries
• 19,059 among newborns in well-baby nurseries
• 417,946 among adults and children in ICUs
• 1,266,851 among adults and children outside of ICUs.

In that year, the estimated deaths in U.S. hospitals were 98,987. Of these:

• 35,967 were for pneumonia
• 30,665 for bloodstream infections
• 13,088 for urinary tract infections
• 8,205 for surgical site infections, and
• 11,062 for infections of other sites.[1]

Nosocomial Infections are an International Problem

In a World Health Organization Survey of 55 hospitals in 14 countries representing four regions, an average 8.7% of hospital patients had nosocomial infections.

What are some of these Infections?

Here is a short list: C-difficile, E-coli, Pseudomonas aeruginous, MRSA and VRE, the main causative agents of hospital derived nosocomial infections.

How bad are some of these?

C. Difficile

C. Difficile is the most serious cause of antibiotic-associated diarrhea (AAD) and can lead to pseudomembranous colitis, a severe infection of the colon, often resulting from eradication of the normal gut flora by antibiotics. Some estimates place the added cost to the healthcare for C. Difficile alone at $17.6 million daily. The CDC estimates that C. Difficile ases in the US may reach 500,000 annually leading to potentially 30,000 deaths.

MRSA

Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for difficult-to-treat infections in humans. MRSA are by definition strains of Staphylococcus aureus that are resistant to a large group of antibiotics called the beta-lactams. CDC reported (JAMA, 2007) that the number of serious infections by MRSA in 2006 was close to 100,000, with approximately 19,000 associated deaths.

Current Methods at Sterilization Are Not Effective Enough

The solution is quite easy in one sense. Just eradicate the infectious diseases from the hospital and the problem is solved. That is prevention. The issue with this prevention is that present methods of cleaning, disinfection and sterilization are not effective. Current cleaning protocols for the sanitization of hospitals have become increasingly ineffective, resulting in an accumulation of deadly bacteria throughout facilities.

Recent research conducted by Microsearch Laboratories demonstrated that, after rinsing and cleaning prior to testing using standard procedures, a cleaning mop collected from a New York hospital was found to have in excess of 150,000 colonies of C. difficile. These results raise concerns about the efficacy of current cleaning and disinfecting procedures.

To make matters even worse, non-medical surfaces, e.g., carpets, bedding and curtains, porous materials in ceilings, once impregnated with highly resistant nosocomial pathogens (in particular, spore formers such as C. difficile) cannot be disinfected with currently available agents and processes. Over time, these pathogens may accumulate in dangerously high concentrations.

Current procedures for the sensitization of hospitals have become increasingly ineffective, resulting in an accumulation of deadly bacteria throughout facilities.

A Solution: Ozone is a Prime Candidate for use as a Sterilization Agent in Medical Facilities

Many people do not realize that ozone had a long and successful history of use as a potent anti-bacterial, anti-fingal and anti-viral agent. Ozone was first used as a disinfectant in 1881 by Dr. Kellog. In 1893 Ozone was used in the Netherlands for water purification. Presently, in excess of 3,000 municipalities around the world use Ozone for water purification.

Research conducted in New York City has also demonstrated that Ozone is effective against Legionella Bacteria, as well as pseudomonas populations in those water purification plants. Ohio State University (2001) demonstrated a 4 log difference in sporicidal action of Ozone vs. Vaporized Hydrogen Peroxide (6.1 log reduction for Ozone vs. 1.6 log reduction for VHP). Microsearch Laboratories has demonstrated (2007) that Ozone is 3,200 times more effective than chlorine.

Why Medizone?

• Medizone has a 23 year history in the field of medical therapeutics with Ozone.
• Medizone has initiated a joint program with Biozone Corporation to develop a state-of-the-art Ozone-based sterilization system (AsepticSure^TM) for medical applications.
• This technology will feature a new “Ozone Destruct” scrubbing system intended to rapidly detoxify hospital working spaces following exposure to Ozone.
• The Medizone technology (AsepticSure^TM) will have an Ozone producing capacity 4 times greater than what is thought to be necessary under normal hospital circumstances.
• The AsepticSure^TM system will also include a gas vaporization component, and a stand alone Ozone scrubbing system, adaptable to all hospital environments and space requirements.

The Leadership:

Edwin G. Marshall – Chairman of the Board & Chief Executive Officer

Following a period of time in which he unsuccessfully attempted to influence and guide former management as a shareholder, a successful hostile proxy action was completed on June 12,1997.

Mr. Marshall took over as Chairman of the Board. Milton G. Adair, former President and CEO of Gull Laboratories was appointed Chief Executive Officer and President. Mr. Adair left the Company to pursue other interests in 1998. Mr. Marshall then took over the additional responsibility of Chief Executive Officer.

Mr. Marshall attended Santa Rosa Community College and the College of Marin, studying fire science and business administration. Until 1978 Mr. Marshall worked in the fire service in a city with a major chemical industrial complex, leaving with the rank of Captain. A successful private investor since 1973 in precious metals, securities and real estate, after leaving the fire service he went to work in the real estate brokerage business. From 1978 until 1995 he pursued various business interests in real estate brokerage, a vacuum forming business in the plastics industry, an industrial computer controls company, and an automobile and truck dealership. Since 1997 he has devoted all of his business time to management responsibilities with Medizone.

Michael E. Shannon, M.A.,M.Sc.,M.D. – Board Member & Director of Medical Affairs

Dr. Shannon received his medical degree from Queen’s University in Canada, which included advanced training in surgery and sports medicine. He also holds post-graduate degrees in neurochemistry and physiology. He has been actively engaged in applied medical research within these areas for over 27 years. He served in the Canadian Forces for 31 years retiring at the rank of Commodore (Brigadier General equivalent) as Deputy Surgeon General for Canada. During the first Gulf War, Dr. Shannon served as the senior medical liaison officer for all of the Canadian forces. In 1996 he assumed responsibilities within Health Canada for re-organizing the Canadian blood system. Working with both the provincial and federal governments he oversaw the development of a new corporate entity dedicated exclusively to the management of blood services in Canada. He was then appointed Director General for the Laboratory Centre for Disease Control, a position he held for three years. In December 2000, Dr. Shannon left the Canadian federal government to pursue a new career in industry. In that capacity he simultaneously directed a phase III clinical trial in Canada, the United States and Great Britain for an artificial blood substitute product. Following completion of that work he was asked to accept a special assignment with the Canadian Federal Government Auditor General’s office. His assignment being to conduct a cost benefit analysis of all government sponsored pharmacare programs and make recommendations directly to the Parliament of Canada. His assignment and presentation to Parliament was completed in November 2004. Dr. Shannon then served on a special assignment to the Canadian Public Health Agency (Center for Disease Control equivalent in the United States) as Senior Medical Advisor. His responsibility was to direct the rebuilding of the Emergency Medical Response Capacity for Canada. In this regard and under his direction, the largest emergency medical response exercise in the history of the country, involving the overnight construction of a mobile hospital, hundreds of doctors and thousands of patients, was successfully held in Toronto in December of 2007.

Dr. Shannon has been actively engaged in medical bio-oxidative (O3 based), research since 1987 and was directly responsible for the first human clinical trial to have ever been approved in North America which examined the efficacy of O3 delivered via minor autohemotherapy in the treatment of AIDS. He was also responsible for several primate studies utilizing O3 involving scientists from various departments within the Canadian Federal Government, as well as senior investigators from Medizone International and Cornell University. Dr. Shannon has served as the Senior Medical Advisor to Medizone International since 2002. In August of 2008 he accepted a position on the Board of Directors of Medizone International and assumed responsibility for medical affairs. In October 2008, he was additionally appointed the President of the Canadian Foundation for Global Health.

Richard Garret Solomon – Director and Executive Officer

Mr. Solomon first invested in Medizone in 1992. In 1995, Medizone New Zealand Limited (a partially owned subsidiary of Medizone International) was formed as a 50/50 joint venture. In January 1996, until February 1997, Mr. Solomon was a Director of Medizone International, Inc. and has rejoined the board as of May 1, 2000.

Mr. Solomon received a Bachelor of Commerce (University of Otago), Diploma of Business and Industrial Administration (University of Auckland), and is an Associate Chartered Accountant. His career has been in business and investment, and for 20 years he developed and ran his own private hospital operating company, Haven Care Hospitals Limited. He was a longstanding Board member and President of the New Zealand Hospitals Association. He lead the establishment of The New Zealand Council of Healthcare Standards, Inc.

Daniel D. Hoyt – Board Member

Mr. Hoyt graduated from Indiana University with a Bachelor of Science degree in General Business Administration in 1962. For the past 31 years, he has been involved in the life insurance and group benefits industry achieving both industry-wide and national company recognition for production and mentorship. Mr. Hoyt takes great pride in the relationships he has built through consultations with his business clients that range from large public companies to small private businesses. Throughout his career, he has served as mentor to many other entrepreneurs. Mr. Hoyt previously worked 7 years as an account executive at Merrill Lynch and as Chief Executive of two and Vice President of one Chamber of Commerce in Indiana. In addition to his board position with Medizone International, Mr. Hoyt is the Chairman of the Board of Biological Systems, Inc., a bio-cleansing, microbial remediation system dealing with natural animal fats and oil-based materials.

Mr. Hoyt is and has been very active in his community and church. These activities and positions include: current board member of the Indiana University Cancer Center Development Board; former board member and chair of Saint Mary of the Woods College, Terre Haute, IN; board chair of Our Lady of Fatima Retreat Center; twice chair of the Parents Association of Ball State University. Numerous other board and leadership positions include St. Elizabeth Home for Unwed Mothers, past president of Indianapolis Sierra Club, Prevent Blindness of Indiana; Indianapolis Business Development Foundation and Christamore Settlement House. He is currently chair of the Rebuild My Church Board of Visitors of Marian College, an active member of Immaculate Heart of Mary Catholic Church and a founding member of Pink Ribbon Connection, a newly formed group serving the needs of breast cancer patients and survivors in central Indiana (he is a 10-year survivor).

Steve M. Hanni – Chief Financial Officer

Mr. Hanni has served as Medizone International’s Chief Financial Officer since April 2, 2002.

Additionally, Mr. Hanni is the Audit Partner-in-Charge and Vice-President of the accounting firm, Stayner, Bates & Jensen, P.C., located in Salt Lake City, Utah. He was formerly a partner with the accounting firm, HJ & Associates, LLC, also located in Salt Lake City. HJ & Associates serves as the Company’s audit firm.

Mr. Hanni has worked closely with many different types of companies and organizations and has extensive auditing and consulting experience in the following industries: Mortgage Banking, Construction, Manufacturing, Oil and Gas companies, Retail, High Technology, Non-profit and Pension Plans.

In addition, Mr. Hanni has significant experience with Securities and Exchange Commission listed companies, including registration statements, public offerings and audits as well as providing management advisory services.

Contact information:

Medizone International, Inc. (OTC: MZEI)

Web:

http://www.medizoneint.com

Telephone:

415-868-0300

Fax:
415-868-2344

Address:

PO Box 742
Stinson Beach, CA 94970

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Section 10

Sector 10, Inc. (OTCBB: SECT) provides solutions to weaknesses and threats in public and private safety and security as well as to World-wide disasters and large-scale humanitarian relief. Sector 10′s mission is to become the world’s leading provider of mobile and stationary emergency life response equipment. Sector 10 proposes to restructure a fragmented industry with its globally patented Mobile and Stationary Response Unit (“MRU” and “SRU”) product lines and “save lives”.

In 2007, Sector 10′s growth strategy identified numerous opportunities nationally and around the world. The strategy remains to: continue to invest in management and business development, expand the number of clients the company covers; be more effective in delivering the entire Firm to their clients; effectively manage risk, capital and expenses; and further strengthen their culture.

Global Perspective

Sector 10 intends on expanding its global presence, bringing premier capabilities to bear where their clients need them. Twenty five countries have called Sector 10 with interest in their services. There have never been more opportunities to serve their clients around the world. Positioning the company to meet their client’s needs and deliver value is at the heart of this strategy.

Focused Strategies

Sector 10 plans to deliver on the US market opportunity and leverage local knowledge as they expanded their global footprint. The company will continue to develop their platform in United States, strengthening their Management and establishing their investments opportunities.

The company’s secondary focus will be to expand their global client base, building new trusted advisor relationships. As Sector 10 extends their global reach, the company will strive to remain rooted in their core competencies – including the effective management of risk, capital and expenses. Finally, as Sector 10 moves into new geographies, they are mindful of the need to continually strengthen the Firm’s culture.

With these goals in mind, in 2008 and 2009, Sector 10 hopes to be better positioned than ever to seize market share and new opportunities globally.

Growing Shareholder Value

Sector 10 remains fully committed to its operating principles – with an opportunity to dominate the emergency response field, and to provide a service to a consumer that remains unaddressed.

Sector 10 is in the right place at the right time to lead a extremely fragmented industry and dominating a tremendous growth opportunity. Tge company’s Client focus, doing the right thing, commitment to excellence and teamwork, ensuring a meritocracy, respecting each other, smart risk management, building and protecting their brand are key focuses in the company’s growth and maximizing of shareholder values.

Company History

From a common sense approach Pericles DeAvila assembled a team at Sector 10 to analyze emergencies on a global scale and how specific disasters and response levels affected human life. The company’s management asked themselves questions. How existing response systems work or fail? How do local, national or communities abroad work or fail in responding to disasters? How humanitarian issues are addressed and without question, victims need tools to help themselves in the initial and critical moment, at the incident scenes. Often before response teams are able to arrive, usually 48 to 96 hours at a minimum a delayed response time currently expected by national response teams.

Sector 10 knows that on arrival the initial focus is to assess the situation and determine who gets what in their limited supply of resources. In a simple example, wouldn’t it have been nice in the darkness of NYC if light kits, reflective vests, and other emergency supplies where available to individuals in pre-deployed locations in their workplace to help themselves and others. Would it have helped curb the respiratory illness now affecting the responders and those that lent a hand on 9/11. That in-depth analysis over the years gave rise to Pericles Logix System, which gave rise to the following conclusions:

The need to pre-deploy an integrated system that allows distributing PPE, emergency response equipment and communications in building structures and public facilities especially within large city center. A system that would make it easy to conduct a floor to floor assessment within high-rises buildings and allow the emergency responders the ability to help and address the needs of the affected in a more efficient and cohesive manner. Basic pre-deployed assets to enhance the escape from building entrapment and to enable better extrication and treatment of victims at the scene. Adding the level of communications available within the system will give the emergency response community the ability to link with the private sector expanding everyone’s capabilities for success and self-sufficiency and increasing the life saving capability and survivability of the affected is a leap forward of imaginable scales. A new picture is painted, not only is there a coordinated effort immediately apparent, also the availability of needed tools in pre-deployed areas become essential.

In time of natural or man made disasters around the world or even when a Nation or anyone exert their power to wage war against a Country the first thing accomplished is usually the destruction of the infrastructure and their ability to self sustain followed by the urgency of humanitarian aid to combat hunger, lack of water, escalating diseases followed by a call for global help to reinstate communications and the ability to provide health-care, a process that can take years. the Pericles Logix System a 21st century solution to million year old problem and its capabilities to establish an instant infrastructure with water purification, mobile clinics, communications with telemedicine capabilities, portable villages, capacities for remote schooling and vocational training, portable HIV testing and medical units such as dental and mammograms is a step in the right direction to address these very serious issues In effect it is a deliverable plug and play multi-functional systems or integration platform to aid in relief of all sizes from a vaccine need to a refugee or displaced population camp with multi infrastructure capabilities Postwar animosity seems to the prevailing response to liberation wouldn’t make a deference in the hearts of the people of Iraq or Afghanistan if they could see the instant fruits of their liberators. A product and system they can continually use to support their communities as a long term solution to current and future needs.

Products

Sector 10 provides a cohesive solution to the disaster at hand through innovative Stationary Response Units (SRU), Stationary Response Units with Media (SRU-Media) and Mobile Response Units (MRU).

SRU and SRU-Media provide pre-deployed resources as a way to save lives, avert injuries and reduce liability. These systems provide first responders and building occupants with first aid supplies, life saving equipment, occupant tracking through a real-time 3D interface, and emergency communications.

SRU-Media, in addition to the multiple benefits listed above, also offer messaging components to generate revenue channels during times of normal operations. SRU-Media include a flat screen video monitor that can be used for advertising, corporate branding and other messaging needs. The revenue model more than offsets the cost of the units and converts a non-revenue, must have device into a completely interactive revenue-generating product.

MRU’s provide the modularity, mobility, customization, and personalization to first responders when they arrive at a disaster site effectively providing a “portable village” — a desperately needed safe environment for victims and emergency professionals so that lives can be saved. These Response Units offer shelter, utilities, comforts, supplies and equipment.

Emergency Stationary Response Units – (SRU)

The SRU mobile Response unit is a stationary response center containing the essential equipment needed for disasters and crisis situations. The unit can be placed near stairways, elevators, and transportation terminals. The SRU units utilize the Pericles Logix System to deliver real time information, evacuation status, communications, and supplies the facilities to aid victims in crisis.

Emergency Stationary Response Units Media – (SRU-Media)

Sector 10 is integrating a new media platform with its SRU product line, called SRU-Media. These units provide all the pre-deployed resources found in Sector 10′s SRU, while offering the ability display various types of advertising, search results, corporate branding, AMBER Alerts, public service announcements, venue directory services, and real-time evacuation instructions.

SRU-Media are placed in high traffic public venues such as airports, convention centers, mass transit stations, entertainment venues, sports arenas and stadiums, and retail locations – wherever the public is found in masses.

These are pre-deployed life saving devices that generate revenue during times of normal operations. The advertising dollars created can more than offset the expense of these multi-purpose units.

Sector 10 has product placement programs that can place SRU-Media in high traffic areas at discounted prices or maintenance only cost to the end user. With the widespread adoption of pre-deployed emergency response systems, Sector 10 is building one of the largest proprietary digital networks in the world.

Emergency Mobile Response Units – (MRU)

Permanently placed MRU’s on location provide the fastest and most efficient security and first aid, working with the incident commander to build a unified command center.

MRU’s are rush delivered to a disaster site to enable disasters to be quelled and victims to treated and saved.

The MRU mobile Response unit is a self-contained response center armed with all the essential equipment needed for disasters and crisis situations. The mobile unit can be delivered to a crisis site to administer first-aid and other medical needs. The unit is deliverable by air-drop or truck hitch mounted lift system.

Markets

Public Safety

Sector 10 provides a mulit-disciplinary team of experts to assist a community or state in assessing need versus budget constraints, then devising large city interoperability / 3D Community Grids and ultimately preparing for and pre-deploying Sector 10 products.

High Risk Areas: Airports, College or Business Campus, Stadiums, Shopping Malls, Subways

Public areas with a high volume of people traffic are prime targets for terrorism or mass casualty incidents. The SRU-Media was designed to fill this need. Making life saving equipment immediately available.

Hospitals

Hospital ER units and ambulances are susceptible to “contamination” from chemicals, viruses, parasites, and other foreign items that challenge the sterilized environment of their operations. When these units are contaminated they must be taken out of service immediately for re-sterilization. This causes two major problems for the emergency service providers. First, there is a tremendous expense to re-sterilizing the units. Second, taking these units out of service takes scarce emergency response resources away from a carefully balanced plan forecasted by emergency managers. Sector 10 mid-size units provide a mobile Decon Shower Unit with the necessary equipment to decontaminate people and equipment before putting them into an ambulance or admitting to a hospital ER unit.

Schools

Schools from K-12 to university have been the unfortunate sites for man-made and natural disasters. The world has not yet forgotten the shootings at Columbine High School or the Northridge earthquake that leveled buildings. Each area of the country has a unique emergency threat based on its own climate and geographical location. When teachers and students exit school buildings after an emergency, it poses an immediate threat of student containment. There are also immediate needs for food, water, first aid, etc. Because Sector 10′s pallet sized unit is stored outside the building on a concrete slab, it can be opened immediately by authorized personnel to inflate a student containment tent and distribute food, water and first aid supplies stored in the MRU. Individual mid-sized units can be distributed inside the school and can easily be moved outside, as needed.

Corporate Safety

Sector10 provides a mulit-disciplinary team of experts to assist corporations in taking their written safety plans to actually response capabilities.

Industrial Buildings

Construction sites and industrial buildings have compliance requirements by several government agencies, including OSHA, EPA, etc. Issues of concern range from safety to emergency preparedness. Emergency warning systems are usually in place, as well as a location for first aid supplies, but these systems are incomplete and the locations are difficult to find. Personal hygiene on a construction site is a typical problem, because running water is not available. Due to the large amounts of chemicals and large machinery at industrial sites, injuries and deaths are a considerable risk. Sector 10′s mid-sized MRU units conform to government agencies’ regulations and are customized to respond to each risk event forecasted by the customer. Due to the size of the MRU, and the emergency strobe light located on top of the unit, it is easily visible to victims and professional support teams.

Office Buildings

Few situations are more terrifying than being trapped in a burning building, which has lost all communications, is rapidly filling with smoke and without any established means for escape.

U.S. buildings need to be equipped with MRUs containing personal protection equipment (PPE). This would include special “smoke hoods” to protect people from deadly fumes. To survive a fire, a person must maintain a clear source of breathable air. A smoke hood is a positive pressure device which keeps toxic gases from entering. It also has a filter design that prevents obstruction from smoke particles, reducing the effects of claustrophobia.

Fires destroy phone lines. This requires independent communications devices for each floor of a building, to allow emergency communications to a disaster incident commander on the ground. The specific target market is the multi-story office building market which are at least 5 stories in height. Sector 10′s small unit provides the needed emergency supplies on a custom basis for each floor of a multi-story building. This creates a multi-unit sale scenario.

Most fire deaths are not caused by burns, but by smoke inhalation. Often smoke incapacitates so quickly that people are overcome and can’t make it to an otherwise accessible exit. The synthetic materials commonplace in today’s homes produce especially dangerous substances. As a fire grows inside a building, it will often consume most of the available oxygen, slowing the burning process. This “incomplete combustion” results in toxic gases.

Mines

Half a mile or mile down in the earth where time is of the essence in any incident and when the unthinkable happens, life and safety are #1.

Humanitarian Relief / World-wide Disasters

Sector 10′s vision spans far beyond the needs of the First World. The scenes of refugees in Afghanistan, Central America, and Africa haunt each of us. The people of these regions suffer immensely in disasters as they have no resources to fall back upon. The Company has a well-developed plan for relieving some of the pain in these Third World countries through the humanitarian deployment of the MRU based technology.

Sector 10′s unique product line allows charitable organizations to quickly solve emergency response problems for third world disaster situations. MRUs can be quickly deployed anywhere in the world by air shipment, even ahead of the emergency teams that are also being deployed to the stricken area. Therefore, the units can be set up as portable villages offering safe havens, supply centers and decontamination facilities for victims. This is very similar to disaster response in the United States, although the supplies would be geared to third world situations and the particular needs of the donating organizations. Sector 10 would therefore be a supplier into the world humanitarian supply network. Although the market is relatively small, the impact is very great in terms of product visibility, wide spread distribution, and good will.

During the first three years, the company would market primarily into the U.S. based organizations such as corporate and private foundations, church relief agencies, U.S. military, government relief agencies and individual donors. Longer term, specialized MRUs could be developed to address typical third world health issues that are non-disaster related, such as dental and eye care needs. These units would be specially equipped for the medical teams serving these needs on a temporary basis worldwide.

Sector 10 also is committing 10% of net earnings to the improvement of medical goodwill globally through the deployment of medical MRU’s.

Management

Pericles DeAvila, President and Chief Executive Officer

Pericles DeAvila is the founder, inventor and creative thinker at Sector 10. He is responsible for all strategic, financial and operational aspects of Sector 10, Inc., and its associated businesses.

Mr. DeAvila is the inventor of the Pericles LogiX System and the Mobile Response Unit and Stationary Response Unit, the core of the Sector 10 product line. He has entrepreneurial experience nationally and internationally with his beginnings in the construction industry. He was a construction manager for 11 years on large projects in Silicon Valley and in Seattle — including Safeco Field, the home of the Seattle Mariners. Mr. DeAvila was a co-founder of Dagcon General Construction, a 375-employee subcontractor in the San Francisco area where he was instrumental in the development of metal frame construction methods for residential homes in the San Francisco Bay area. Mr. DeAvila founded DeAvila Homes, a condominium development company in Seattle.

Mr. DeAvila studied business and construction management in California and also studied at the Institute University of the Azores. He is fluent in Portuguese, Italian, French, Spanish, as well as English.

Larry Madison, Chief Financial Officer

Larry Madison is responsible for all aspects of financial management and reporting for Sector 10, Inc, and its affiliate companies. Mr. Madison has more than 30 years experience in public accounting. He comes to Sector 10 from the Chicago office of the international accounting and management consulting firm Grant Thornton International where he served in the tax quality assurance department. Prior to his work at Grant Thornton, Mr. Madison worked for 15 years in Big Four accounting firms and for 15 years running his own accounting consulting firm where he specialized in providing CFO services to small, private companies and in raising capital for start-ps. Mr. Madison brings Sector 10 experience and expertise in Sarbanes-Oxley compliance and corporate governance. Mr. Madison is licensed in Illinois as a Certified Public Accountant. He has a Bachelor of Accounting degree from Purdue University and a Master of Science in Taxation degree from DePaul University.

Matthew Bain, Senior Vice President, Products and Network

Matthew Bain is responsible for all aspects of the daily operation of the business

Mr. Bain brings a strong background in sales, operations, manufacturing automation, and communications technology to Sector 10 management. He has successfully started and run his own enterprises and filled key leadership positions in a variety of organizations. In recognition of his achievements at Avante Window Company Mr. Bain was a nominee for the prestigious Entrepreneurial Small Business of the Year awarded by the Salt Lake City Chamber of Commerce in 1998

Mr. Bain holds a Bachelor of Science degree in mechanical engineering and a Master of Business Administration degree, both from Brigham Young University

Jim Powell, Vice President of Advertising

Jim Powell is responsible for advertising sales and placement on the Sector 10 SRU-Media units following placement in a client facility. Mr. Powell has a media and consulting background that has spanned nearly two decades. He has helped companies launch local and national advertising campaigns, set up and manage a nationwide sales force, launch new worldwide products, negotiate all types of media buys and find new venture capital. Mr. Powell has worked as Director of Sales for DBS Communication and Marriott Consulting, and held positions as National Sales Manager and Local Sales Manager for a FOX-affiliate television station. He served as President of Fortune Marketing, a Salt Lake City-based advertising, marketing and consulting company. He has worked as an account executive in advertising sales for local NBC and CBS affiliates and for AT&T Cable

Mr. Powell holds a Bachelor of Arts degree in Communications with an emphasis in Broadcast Media Sales from Brigham Young University

Paul Pugmire, Vice President of Communications

Paul Pugmire is responsible for the corporate message and brand, external and internal communications, and relationships with government, media and corporate stakeholders

Mr. Pugmire has a history of broad experience and significant accomplishment in communication and public affairs. He has served as press secretary, legislative assistant and district representative to U.S. Representative Richard Stallings and as assistant to Minority Leader Art Hamilton in the Arizona House of Representatives. He was Director of Sports Development for the State of Arizona, a governor-appointed position responsible for retaining Major League Baseball spring training and developing Arizona as a major sports venue. He was Director of Public Affairs for Argonne National Laboratory-West where he managed the emergence of the Laboratory as a known and respected corporate citizen. He has been a member and president of the Rexburg, Idaho City Council, has served on several local, state and national community and professional boards and committees and has successfully owned and operated small businesses

Mr. Pugmire holds a combination Bachelor of Arts degree in English and Communication from Boise State University and attended graduate school in political science at Arizona State University

Lance Ellsworth, Vice President of International Sales

Lance Ellsworth is responsible for recruiting qualified and motivated licensees to distribute Sector 10 products in foreign countries and for negotiating and overseeing those licenses

Mr. Ellsworth is an experienced sales and marketing executive with more than 14 years experience in the Internet, software, and telecommunication industries. Prior to joining Sector 10, Lance was a partner and VP of Business Development for Kairoscorp, a company he spent 3 years building and sold to Techwerks, Inc. Prior to that Lance was VP of Sales & Marketing for Internetumbrella.com, where he crafted strategies, developed business plans, and raised funds for multiple companies

Previously, Mr. Ellsworth was Director of Channels and Business Development for Assist Cornerstone Technologies, a leader in web and financial applications. For Harbinger Corporation, a publicly traded e-commerce/e-business company, Mr. Ellsworth served as Senior Sales Executive with responsibility for the North American market

Mr. Ellsworth holds a Bachelor of Science in Psychology from Brigham Young University and a Masters of Business Administration from the University of Utah

Colby Haas, Sales Engineer

Colby Haas is responsible for technical support of the sales and delivery process

Mr. Haas brings a broad and varied practical experience as an equipment technician to Sector 10. He helped develop a revolutionary floor cleaner which was patented and for which he was responsible for more than six years. He is proficient in Solidworks, CNC machining, product prototyping, and production

Mr. Haas started and ran a product design business where he designed products such as BBQs, outdoor equipment and window automation equipment from molds and tooling.

Contact Info.

Sector 10

14553 South 790 West, #C
Bluffdale, Utah 84065

Phone:

(801) 478-2475

Toll Free:

(866) 922-9533

Email:

info@Sector10inc.com

Website:

http://www.sector10inc.com/

Investor Relations:

ir@Sector10inc.com

Disclosure: Pentony Enterprises LLC has been compensated 100,000 free trading shares from a non-controlling third party for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Zaldiva, Inc. (OTCBB: ZLDV) is poised well to deal well with the worldwide recession. When we reached out to cover this company, we were impressed with the company for a couple of very significant reasons. One of those reasons you will read about in detail in this profile is its “Direct to E-Auction” business which essentially is well explained in this July 28, 2008 press release from the company – SEE IT HERE. Zaldiva is headquartered in Florida, and it is a requirement within Florida to register as an auctioneering house in order to offer a drop-off service to sell client owned merchandise on eBay or similar sites. Most competitors simply do not have the resources or the good name to get this license.

With the economic downturn, this is becoming the most significant revenue and profit center for the company. With the Zaldiva reputation in the business and its Powerseller reputation on Ebay, it is the natural first choice for individuals who need to liquidate their collections for maxium return. For the collectors and buyers, there is no better company to buy from.

We present to your our profile for Zaldiva. We welcome any questions or comments you might have.

Corporate Summary

 Zaldiva is a distribution system unique to the specialty retail industry. The company combines a highly visible brick and mortar location in Ft. Lauderdale, Florida with an e-commerce website and portal which operates in conjunction with a series of ancillary websites and online auctions. This system is the foundation of the company’s business and marketing plan as well as its vision and mission statements.

Zaldiva focuses its product orientation on the comics and collectibles genre of the specialty retail industry. This not only plays to the management’s expertise, but allows the company to operate in an economic subset that is recession averse and not subject to seasonal or market trends. Products that flow through the company’s distribution nodes include, but are not limited to comic books, statues and figurines, DVDs, posters, dolls, action figures, T-shirts, die cast vehicles and automobiles.

The company began operations in 1997 as a specialty retail outlet for cigars and related items. Along the way, Zaldiva added web hosting and e-commerce related services. In and around 2003 the company decided to change its operational structure and focus, dropped the cigar aspects and moved into the comic book and collectible arena.

Nicole Leigh–van Coller and her husband Jeremy have long been collectors of comic books and memorabilia related to comic books and movies. It is one of their true passions and one that they decided to turn into a business. “It is much easier to put your heart and soul into a business that you love, than one which is just about the bottom line,” stated Ms. van Coller. The first few years, from 2003 to 2006 were spent building inventory, acquiring and preparing the building on Commercial Boulevard in Ft. Lauderdale and putting the business structure in place for the future.

It was at this juncture where the management team’s e-commerce experience was truly defined as a value proposition. In web jargon, “stickiness” is an important term. It helps to define how valuable a piece of internet property is by showing how long a visitor stays at the site, and how many aspects of the site the visitor “hits” and or takes commercial advantage of. Potential advertisers like sites with high “stickiness” levels because their messages will be seen more often and for longer periods of time. Also visitors will at some point conduct business. With Zaldiva, the mindset is “how can we increase the time visitors will spend at our location(s) as well as the probability that they will purchase something?” This is why their product lines are as diverse and deep as they are. However, this focus also lead to one of the company’s most promising business nodes – “Direct to ebay.” It came into being when management realized that a definable percentage of visitors with product to sell were leaving without conducting business. After analyzing the visitor’s item, Zaldiva would not meet the seller’s price. Management realized that while they may not be willing to purchase the item at the seller’s price – someone might.

Direct to eBay

The “direct to eBay” feature is a way the company is increasing its distribution scale and keeping more clients at Zaldiva. The company structured an offering where they would do all of the work to offer and sell the item online. Zaldiva then retains a significant percentage of the proceeds. This met with a resounding, positive response and has grown beyond its initial scale. It also maintains the focus of Zaldiva as a distribution system, not simply a retail organization. The company is now actively seeking product to distribute in this manner, both in the area of corporate/retail inventory and automobiles.

2007 was the transition year from formation to business operations. For the first quarter (fiscal) 2008 ending in December 31, 2007, the company’s revenues increased almost threefold from $27,635 to $79,353, with sales a gross profit of $35,840. Based upon the existing model and property structure, Zaldiva can, and expects to increase revenues within 12-18 months to $240 to $300k per quarter. While the company did show an after tax and expense loss of $.02 per share for fiscal 2007, cash increased from $26,827 from the end of fiscal first quarter 2007 to the end of fiscal first quarter 2008 to $62,944. In 2006 the company incurred significant expenses for infrastructure, real estate acquisition and other business building activities. Much of the staff salaries were taken in stock, which for accounting purposes were expensed against income. Much of the current expenses are fixed and while cash flow is positive in terms of EBITDA (earnings before income taxes, depreciation and amortization), the company expects positive earnings per share after taxes, interest, depreciation and amortization in the foreseeable future. As the company does anticipate incurring non-cash and non-income related expenses with its planned acquisitions, this may affect the date where that will occur. However, no acquisition will be made that does not positively affect cash flow and the business plan and structure of the company and/or shareholder equity.

What began as a dream is now a multi-phased, multi-level distribution system, focused on the comic book/collectible specialty retail industry. The upside potential for replication and growth is significant.

Current Operations

Zaldiva purchased an existing structure at 331 East Commercial Boulevard in Ft. Lauderdale, Florida on November 24, 2006. After a total reconstruction of the building, the company is now recognized as the best retail outlet of its kind in Palm Beach and Broward Counties (New Times Reader’s Choice Awards 2007). The company estimates that its efforts have also significantly enhanced the value of the property, which is also fully owned, with no debt/mortgage. The property not only is well placed for retail sales (located on one of Broward Counties busiest streets and three blocks from Interstate 95) it also acts as a major, and free source of advertising with front signage and costumed agents seen by thousands daily during rush hours when automobile traffic is busiest – and slowest. Zaldiva is focusing efforts on maximizing its sales per square foot. One of the company’s most successful marketing programs to date has been its weekly, “Wednesday is New Issue Day.” While new comic book issues come out on Wednesdays industry-wide, Zaldiva adds its own flavor – making the day eventful. The profit margin on in-store products ranges from 35 to literally thousands of percentages. For example: Comic books are purchased from selling clients for one to five cents apiece and then re-sold to buying customers for anywhere from fifty cents to ten or twenty dollars. In-store products are also available online, increasing their exposure and rate of inventory turnover.

Zaldiva has had an online presence since 2001 when it offered specialty cigars, web-development and web-hosting services. Beginning in 2003, the company began to focus its efforts on comic books and pop culture collectable products and moved away from service type offerings. The company currently uses the internet to offer its products either via auction or in its set-price e-store.

In a recent development, Zaldiva has expanded its distribution system to allow for large ticket items, inventory liquidations and other higher-end transactions. The idea came from the desire to keep business at Zaldiva, even when a seller’s price could, or would not be met by Zaldiva. The company decided to allow sellers to use its eBay system to try and achieve their desired price, and Zaldiva takes a cut of the sales proceeds. With its Gold level Ebay ratings (Zaldiva is an Ebay Gold Power Seller), e-frontage and sales experience, this is quickly becoming a significant revenue stream. It is also an avenue the company will be expanding through marketing efforts and initiatives. For example: The company has already sold automobiles using this system, and has approached, with a decidedly positive feedback, pre-owned automotive sales organizations to represent fleet level and lot-sized offerings. 

Consumers in this market do not acquire their books at the popular mega-book outlets such as Barnes & Noble or BooksMart. The reason being that the books are all too often already leafed through, creased and not in pristine condition. Consumers also do not wish to climb over reams of youngsters reading the latest editions while their parents peruse other sections.

Another reason consumers of this product utilize specialty shops over mass market venues is who they are. The typical consumer likes to talk about their purchase with people that understand not only the series they are interested in, but in the collection aspects of the items as well. This is especially evident in the resale marketplace, where the larger stores simply do not carry the items at all. There is an inherent value in being able to see, compare and talk about the 12 cent version of Spider-man with the newest edition with someone who not only has the 12 cent version available for comparison, but is fluent on the storylines, current valuations, collectible value and “speaks the genre language.”

A key aspect to why specialty retail outlets are preferred by consumers is the vertical product line offerings. Having the comic book available with other collectibles such as the action figures, movie and character posters as well as other artwork is critical to attracting and keeping clientele. Being able to articulate the value of a total collection, aspects of the series, artwork and writing is invaluable. Specialty retail outlets have the ability to hire such expertise as well as offer the entire vertical product line. It is similar to the retail concept of accessorizing. (i.e. offering the handbag with a shoe purchase or having a shoe department close to the clothing lines)

Zaldiva vs. Other Specialty Stores/Chains

In the specialty retail store marketplace, there are a few key elements that separate successful operations
from those that will end up either being absorbed or replaced.

• Diversity of Product Offerings – Having a complete inventory that includes collectibles, allows for purchase from customers and offers a wide cross section of the comic book and collectible consumer is both unusual, and important. Having, as Zaldiva does, multiple lines of merchandise, as well as a diverse offering of comic books by theme, type and age group is a key success element.

• Product Knowledge – This sounds like a given, however many small outlets are run by people with a modicum of product knowledge. Often, it is limited to what the storeowner happens to favor. The staff at Zaldiva has a deep and varied knowledge base that is unsurpassed in the industry. This is critical not only for discussion with clients, but with the purchase of inventory from the public, and at what prices; knowing what will sell and what will not, being able to spot a bargain and also knowing what years a certain product type is attractive at and what years it is not (i.e. – comics from the 30’s to 40’s value vs. not getting those from the ‘90s). This is very similar to the numismatic collectible industry. Zaldiva only purchases limited editions. Also, clients like to know they are getting a fair deal and can talk to the proprietor with confidence..

• Proper Layout – All too often, the small retail outlets are dark and dingy with just a few rows of comic books on racks. Zaldiva has a large, wide-open array of comic books, collectibles, statues, artwork and more in a very clean, hospitable and “cool” atmosphere. The music is current and the store is family friendly and easy to navigate.

Zaldiva is one of very few companies in its field that is able to ship internationally. It also is unusual in its internet presence, holding a Gold Powerseller rating on ebay.

“One of the things that makes us different from other retailers of our kind is our store. We designed it to have a ‘wow’ factor that not only has customers coming in the store, but staying in the store and looking at everything we offer. People like everything from our music, to how clean and bright our store is. Everything is eye catching and we like it that way. It is a place where adults feel good shopping – and to bring their children.” Jeremy van Coller, Director/COO.

Robert B. Lees.

Mr. Lees, age 61, is a graduate of the U.S. Naval Academy. He served as an Officer in the Marine Corps, both overseas and domestically. After transferring to the active Reserves, he joined the DuPont Company, where he managed the Southeastern Region. He took the region from last to first in the acrylic sheet division for sales and service. He then became part owner and general manager of a wood laminating operation in Orlando, Florida. Upon the sale of the business, he joined Merrill Lynch in the Private Client Group and became an assistant Vice President. He has since consulted to a Florida-based investor relations firm, and served as President and Chief Operating Officer of two start-up companies, as well as his current position.

Ms. Leigh-van Coller

Ms. Leigh-is 37 years of age. She is a 1989 graduate of Washington High School in Phoenix, Arizona. For the past five years, she has been significantly involved in the Company’s operations, including web site design and maintenance, inventory and shipping, online sales fulfillment and general operations. 

John A. Palmer, Jr.

Mr. Palmer is 70 years old. He is a graduate of the University of Wisconsin, where he received a BS in Mathematics and Physics and an MS in Education and Counseling. He has continued his education throughout his life and has completed multiple workshops in Electromechanical Automation, Electromechanical Systems, Vacuum Technology, Vacuum and RF Power and Semiconductor Manufacturing Processes. He was a presenter for Basic Troubleshooting and Electromechanical Devices at the Intel/MATEC Summer Institute, Arizona as well as for the transducers Workshop in Orlando, Florida and the Rockwell automation PLC Workshop in Michigan. Since 1969, Mr. Palmer has served as a Professor of Electricity, Industrial Electronics, Manufacturing Electronics and Mathematics at the Central Arizona College in Coolidge, Arizona. In addition, he has been involved in Summer Faculty Internships at Motorola and Intel, both in Phoenix, Arizona.

Jeremy I. van Coller

Mr. Van Coller, age 29, is a graduate of Kloof High School (Kwa Zulu Natal, Kloof, South Africa) where his line of studies included Technical Drawing (architectural renderings), Biology, Advanced Mathematics, English and Afrikaans. He continued his education by attending the Academy of Learning (Kwa Zulu Natal, Pinetown, South Africa) where he studied Marketing, Management and Computer Science for approximately 

  Contact Information:

Zaldiva, Inc.

331 E. Commercial Blvd.
Oakland Park, FL 33334

Phone: (877) 925-3482
E-mail: info@zaldiva.com

http://www.zaldiva.com
Investor Awareness for Zaladva:

IRth Communications, LLC
520 Broadway, Suite 350 #111
Santa Monica, CA 90401

Phone: 866-976-IRTH (4784)
Fax: 949-861-6388

Disclosure: Pentony Enterprises LLC has been compensated twenty-seven thousand dollars for profile coverage by a non-controlling third party. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

NEW YORK (AP) — Wall Street has managed its second straight comeback, but the rebound was more a sign of the market’s turmoil than strength.

Stocks closed moderately higher Friday after an erratic session that had investors tussling with concerns about the ongoing problems in the banking industry in response to more billion-dollar losses at Citigroup Inc. and Bank of America Corp. Yet investors were also heartened by plans for both banks to restore themselves to profitability, and they were also willing to place bets on a range of consumer and industrial stocks.

“It’s that tug of war between problems and promise,” said Alan Gayle, senior investment strategist at RidgeWorth Investments. “I think there is a bit of a sigh of relief that there is assistance coming for Citi and Bank of America, but it seems like there is an ongoing need for this assistance.”

The companies’ fourth-quarter losses — Citi said it lost $8.29 billion, while Bank of America lost $2.39 billion — were sobering reminders that the sagging economy is aggravating the problems that began with the mortgage crisis in 2007.

READ FULL STORY

Vital Products, Inc. (OTCBB: VTLP) is ready for success.  The bio-based foam packaging product market is estimated to be a nine hundred million dollar market.  That is very close to one billion dollars.  And in this market there are four major purchasers. 
For the four major purchasers of Vital Products bio-based foam product Vital Products has determined these potential purchasers will be able to convert to Vital’s bio-based packaging product without additional expense.  Potential purchasers can use the equipment they have in place.  There will be no conversion expense – which obviously, makes Vital’s bio-based foam packaging product EASY TO LIKE. 
Vital Products is in the process of negotiating with potential users of their product.

After demonstrating the product to potential purchasers Vital Products has determined that the cell structure of their foam chemical was smaller and more consistent than products currently being used which resulted in greater cushioning characteristics.
On an environmental front the off gassing – or the gas that is created when the chemical is put in place and begins to foam up — was 30 to 40% less and the odor was not acidic.

Vital Products has been doing what all company’s do:  setting appointments with potential purchasers and showing off their product.  This provides the opportunity to discuss the needs of companies for their product and allows Vital to lay the foundation to grow their business from their twenty year traditional packaging base.

Vital Products intends to capture a sizeable portion of the nine hundred million dollar foam in place market with its new patent pending foam product that will hit the market at better than competitive prices.

1.       Vital Products bio-based foam costs less than current products.
2.       Vital Products bio-based foam has greater cushioning characteristics than current products.
3.       Vital Products bio-based foam produces significantly less gas than current products.
4.       Vital Products bio-based foam will work with existing application equipment.
5.       Vital Products bio-based foam is a GREEN product from renewable sources.

The time to look at VTLP is clearly, NOW!!!

Disclosure: Pentony Enterprises LLC has been compensated 175,000 free trading shares from a non-controlling party for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. We currently hold no shares. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

The world’s largest software maker also disclosed deals to make its Live Search programs the default search engines on more personal computers and mobile phones. And it announced a new version of its Ford Sync in-car technology that folds in the voice-operated directory service TellMe, which Microsoft bought in 2007.

For years, the opening keynote at CES belonged to Microsoft Chairman Bill Gates, whose status as industry pioneer justified the sweeping visions of the future he’d build into his speech. Gates passed the mantle on when he stepped down from day-to-day operations at Microsoft last summer, and Wednesday marked Ballmer’s first time making the high-profile address.

“It feels like we’ve entered a period of reduced expectations, a time when we may be tempted to temper our optimism and scale back our ambitions,” Ballmer said, in a nod to the recession. “But no matter what happens with the economy or how long this recession lasts, I believe our digital lives will only continue to get richer.”

Ballmer said Microsoft would continue to invest more in research and development than its technology peers.

The CEO announced that a nearly final “beta” test version of Windows 7 will be available Friday for regular PC users to download and tinker with.

The new operating system — which could be available for purchase on PCs within a year — uses much of the same underlying technology as its predecessor, the much-maligned Vista. But Windows 7 aims to resolve many problems PC users had with Vista. For instance, Microsoft pledges to make it easier to install peripheral devices and to have the software pump out fewer annoying warnings and notifications.

Ballmer also pledged that Windows 7 will boot faster and drain laptop batteries more slowly.

“I believe Windows will remain at the center of people’s technological solar system,” Ballmer said. “We’re putting in all the right ingredients: simplicity, reliability and speed, and we’re working hard to get it right and to get it ready.”

Ballmer is hoping to boost the number of people using Microsoft’s Live Search engine, which ranks well behind Google Inc. and Yahoo Inc. in popularity, through a deal with PC maker Dell Inc. Dell will put a special Live Search browser toolbar and Windows Live programs, including Microsoft’s e-mail and instant-messaging applications, on most of the consumer and small-business PCs that it sells worldwide. That deal replaces a relationship between Dell and Google.

Tokyo and HK fall 4 pct

The Tootie Pie Company, Inc. (OTC BB:TOOT.OB - News), a premium baker and seller of high-quality, handmade pies; is pleased to announce that their pies are now being sold and distributed by Cheney Brothers, one of the largest food service distributors in the South. Cheney Brothers serves restaurants, hotels, and many other foodservice outlets across the entire state of Florida from three separate distribution centers located in Ocala, Orlando and West Palm Beach.